Skin Cancer: Updates and Supportive Care Strategies
Description: This activity is intended to educate pharmacists on the updates in skin cancer treatment including basal cell and melanoma. Treatment recommendations continue to change as new therapies are approved in both basal cell skin cancer as well as adjuvant and metastatic melanoma. New approvals will be discussed including indications, study results, and side effects. Cases will be presented to discuss pharmacists' role in side effect management.
This recorded activity is a based on a live program that was offered on October 14, 2016 in Burlington, MA.
Participants who received credit for the live program should not claim credit for this web based presentation.
System Requirements for Participants:
Operating system:• Windows XP, Vista or 7 • MAC OS X• Latest Version of Adobe Reader
Browser: • Internet Explorer 8.0 or above • Google Chrome 16.0 or above • Firefox 7.0 or above • Safari 5.0 or above
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Requirements for CE Credit
Complete the pre-test
Review the content of this activity
Successfully complete the post-test with a score of 80% or higher
Complete the activity evaluation
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation is completed.
Pharmacists - Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits will NOT be reported.
The presenter is LeAnn B. Norris, PharmD, BCPS, BCOP; Associate Professor, South Carolina College of Pharmacy, University of South Carolina
Dr. Norris is on the advisory boards of GlaxoSmithKline and Taiho
The reviewer is Steven L. D'Amato, RPh, BSPharm; Executive Director, New England Cancer Specialists; President of the Association of Community Cancer Centers; Clinical Associate Professor, Tufts University School of Medicine
Mr. D'Amato does not have any relevant financial relationships with any commercial interests
Support for This Activity:
This activity is supported by the Association of Community Cancer Centers (ACCC)
American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. American Health Resources does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is intended to educate pharmacists on the updates in skin cancer treatment including basal cell and melanoma. Treatment recommendations continue to change as new therapies are approved in both basal cell skin cancer as well as adjuvant and metastatic melanoma. New approvals will be discussed including indications, study results, and side effects. Cases will be presented to discuss pharmacists' role in side effect management.
Discuss the approved therapies for basal cell carcinoma.
Evaluate the new recommendations for adjuvant therapy for metastatic melanoma.
Apply supportive care strategies to case specific issues.
LeAnn B. Norris, PharmD, BCPS, BCOP
Associate Professor, University of South Carolina College of Pharmacy
Brief Bio : Dr. LeAnn Norris completed her Pharm.D. degree at the University of South Carolina College of Pharmacy in Columbia in 2004. After graduation, she completed a PYG1 residency at the Moses Cone Health System in Greensboro, North Carolina. In 2006, she completed her PGY2 residency at the Regional Cancer Center within the Moses Cone Health System in Greensboro.
Dr. Norris is now an associate professor at the South Carolina College of Pharmacy. She was the 2010 recipient of the Hematology/Oncology Pharmacy Association New Practitioner of the Year Award. Her research interests include supportive care, hospice/palliative care issues, and medication safety